Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”I’ve recently taken on the role of Managing Editor for Therapeutic Advances in Cardiovascular Disease, a gold open access journal dedicated to advancing clinical care across the full spectrum of cardiac and circulatory conditions.
The journal is shaped by a global community of researchers and clinicians who care about evidence that informs real treatment decisions — from pharmacological innovations to interventional strategies and other therapeutic approaches that move us closer to precision cardiovascular care.
Always glad to connect with researchers and clinicians helping to shape the conversation in cardiovascular care — whether by sharing their research or contributing to the journal’s editorial community!”
Find the Journal here.
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100
-
Jul 23, 2026, 19:11Jecko Thachil: Chlorosis May Have Represented Iron Deficiency in the 19th Century
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology